SUSCEPTIBILITY OF ANAEROBES IN PHASE-3 CLINICAL-STUDIES OF PIPERACILLIN TAZOBACTAM

被引：7

作者：

JACOBUS, NV

IMMERMANN, FW

GUPTE, JM

TESTA, RT

机构：

[1] Medical Research Division, American Cyanamid Company, Lederle Laboratories, Pearl River, NY

来源：

CLINICAL INFECTIOUS DISEASES | 1993年 / 16卷

关键词：

D O I：

10.1093/clinids/16.Supplement_4.S344

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：S344 / S348

页数：5

相关论文

共 4 条

[1] SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP IN THE UNITED-STATES - ANALYSIS BY SITE OF ISOLATION
CUCHURAL, GJ
TALLY, FP
JACOBUS, NV
ALDRIDGE, K
CLEARY, T
FINEGOLD, SM
HILL, G
IANNINI, P
OKEEFE, JP
PIERSON, C
CROOK, D
RUSSO, T
HECHT, D
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) : 717 - 722
[2] COMPARATIVE INVITRO AND INVIVO ACTIVITIES OF PIPERACILLIN COMBINED WITH THE BETA-LACTAMASE INHIBITORS TAZOBACTAM, CLAVULANIC ACID, AND SULBACTAM
KUCK, NA
JACOBUS, NV
PETERSEN, PJ
WEISS, WJ
TESTA, RT
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1964 - 1969
[3] [No title captured]
[4] 1990, M11A2 NAT COMM CLIN